It is further alleged the manufacturer put profits over patients as they received reports of adverse events related to the use of Ozempic but failed to update labeling or recall the medication
" We're going to have a pretty robust demand and we just wanted to make sure we had a partner that they could fulfill those prescriptions once they came in." Andrew Dudum, CEO and co-founder of Hims & Hers, said the company leveraged its "size and scale to secure access to one of the highest-quality supplies of compounded GLP-1 injections available today." "Were passing that access and value along to our customers, who deserve a high standard of clinical safety and validation to meet their goals, and we're doing it in a safe, affordable way that others cant deliver," Dudum said
Tesamorelin + Ipamorelin - GHRH Analog and Ghrelin-Receptor Peptide Blend, Research Reference Material FOR LABORATORY RESEARCH USE ONLY
This paradoxically means that even though fat stores are releasing these vitamins, overall levels can still decline because the body is processing them faster than they are being replaced
Where Human Evidence Is Still Limited Human evidence is limited for injectable GHK-Cu, systemic anti-aging, hair loss treatment, chronic disease treatment, liver repair, cognitive benefit, and broad regenerative medicine claims
"These unlawful marketing and sales practices, including the use of Novo Nordisk trademarks in connection with these practices, have created a high risk of consumer confusion and deception as well as potential safety concerns," the company said in a June news release.
